Capricor Therapeutics Inc (CAPR)

Finanzdaten der Capricor Therapeutics Inc-Aktie (CAPR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	59.41% 4.9069	12.09	6.1858	3.9175	2.9867
Operating Expenses	13.49% 15.17	13.37	13.05	11.66	11.17
Benefits Costs and Expenses	14.40% 14.70	12.85	-	-	10.75
Costs And Expenses	14.40% 14.70	12.85	13.05	11.66	10.75
Operating Income/Loss	701.21% -10.27	-1.2813	-6.8646	-7.7473	-8.1847
Nonoperating Income/Loss	9.12% 0.4718	0.5192	0.474	0.3807	0.4164
Income/Loss From Continuing Operations Before Tax	1,185% -9.7941	-0.7621	6.1858	-7.3666	-7.7683
Income/Loss From Continuing Operations After Tax	1,185% -9.7941	-0.7621	-6.3906	-7.3666	-7.7683
Net Income/Loss	1,185% -9.7941	-0.7621	-6.3906	-7.3666	-7.7683
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,294% 31.35	1.3095	25.82	25.34	25.25
Diluted Average Shares	2,294% 31.35	1.3095	25.82	25.34	25.25
Basic Earnings Per Share	1,650% -0.31	0.02	-0.25	-0.29	-0.31
Diluted Earnings Per Share	1,650% -0.31	0.02	-0.25	-0.29	-0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-